| |
|
|
|
BioCryst Pharmaceuticals Inc.  
|
|
2.325 0.085 (0.04%) |
11-22 14:54 |
|
Open: |
2.37 |
Pre close: |
2.24 |
Target:
|
2.93 
|
|
High: |
2.38 |
Low: |
2.16 |
Resistance:
|
2.51
2.93
|
|
Volume: |
2,647,063 |
Market Cap: |
358M |
Support:
|
1.81
1.38
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
2.08
 |
MACD |
MACD(12,26):
|
-0.09 |
|
MA(20): |
2.01 |
Signal(12,26,9): |
-0.16 |
|
MA(100): |
2.76 |
Stochastic Oscillator |
%K(14,3):
|
90.88 |
|
MA(250): |
5.52 |
%D(3): |
78.19 |
|
Average Volume(K) |
3-Month: |
212447
|
52-Week |
High:
|
9.95 |
|
10-Days: |
541301 |
Low: |
1.38 |
|
RSI |
RSI(14):
|
57.18 |
Change(%): |
-75.1 |
|
Financials, Statistics and Valuation |
|
EPS |
-1.213 |
Return on Equity (ttm) |
-845.7 |
Shares Out. (M) |
110.44 |
|
EPS Est. Current Year |
-0.750 |
Return on Assets (ttm) |
-54.9 |
Shares Float (M) |
94.15 |
|
EPS Est. Next Year |
-0.780 |
PEG Ratio |
-0.06 |
% Held by Insiders |
1.04 |
|
EPS Est. Next Quarter |
-0.180 |
Qtrly Rev. Growth |
22.1 |
% Held by Institutions |
93.64 |
|
Forward EPS |
-0.900 |
Gross Profit (p.s.) |
-0.586 |
Shares Short (K) |
14870 |
|
Book Value (p.s.) |
-0.370 |
EBITDA (p.s.) |
-1.022 |
P/E |
-1.91 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
-6.27 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-103.12 |
P/S |
21.09 |
|
Operating Margin |
-959.61 |
Levered Free Cash Flow
(M) |
-48.77 |
P/CF |
-2.48 |
|
|
|
|
|
|
